Group B Streptococcus: Attitudes to Immunisation in Pregnancy
Attitudes to Immunisation Against Group B Streptococcus During Pregnancy in England and Scotland
1 other identifier
observational
758
1 country
4
Brief Summary
Group B Streptococcus (GBS) is the commonest cause of severe infection and meningitis in babies under 3 months in the United Kingdom (UK). About one in ten babies with GBS infection die and half of babies with GBS meningitis are left with long term problems with their development. Vaccinating pregnant women against GBS in order to protect their newborn babies is a promising area of research.However, many women are reluctant to accept vaccination during pregnancy for fear it will harm their unborn child and there is often a lack of understanding of both the vaccine and the condition it aims to prevent. Nevertheless, the recent positive experience of immunisation against pertussis in the United Kingdom, suggest that antenatal immunisation can be acceptable. Previous research has shown that advice from maternity healthcare professionals regarding vaccination is highly valued by pregnant women so it is also important to explore the attitudes and opinions of this group. The objective of this study is to assess the knowledge and attitudes of pregnant women and maternity healthcare professionals in England and Scotland regarding GBS disease and the acceptability of a potential vaccine. There are two parts to this study. The first part will invite pregnant women, maternity healthcare professionals and parents who have had a child affected by GBS disease to take part in either a focus group or an individual interview. This will allow for an in-depth exploration of the participants thoughts and opinions about GBS and vaccination in pregnancy. This part of the study will take place at the Oxford site only. The results will guide the development of a self completed, paper questionnaire which will be distributed to a wider range of pregnant women and maternity healthcare professionals across four different study sites. This study has been funded by Meningitis UK. Additional collaborators to those listed include the charity Group B Strep Support.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2014
Shorter than P25 for all trials
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 10, 2013
CompletedFirst Posted
Study publicly available on registry
November 13, 2013
CompletedStudy Start
First participant enrolled
January 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
March 29, 2014
CompletedApril 5, 2018
April 1, 2018
2 months
October 10, 2013
April 3, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The attitudes of pregnant women and maternity healthcare professionals towards vaccination against Group B streptococcus in pregnancy
The attitude of pregnant women and maternity healthcare professionals will be measured using their responses to questions asked during interviews or focus groups
Single timepoint at interview or focus group lasting on average 1-2 hours
Other Outcomes (1)
Attitudes of pregnant women to participating in a clinical trial of a GBS vaccine
Single time point at interview or focus group lasting on average 1-2 hours
Eligibility Criteria
Pregnant women aged 18 years and over of any gestation receiving antenatal care in the Oxford area (part one and two) or within Imperial college and St Georges's NHS trusts in London and Edinburgh Royal infirmary (part two). Maternity healthcare professionals (midwives and doctors)working in the above areas. Parents who have had a child with Group B streptococcal disease (part one only).
You may qualify if:
- Pregnant women aged 18 years and above who have not previously had a child with GBS disease and are willing and able to give written, informed consent and are able to read and speak English. OR
- Obstetricians (including consultants and trainees) or midwives working at one of the study site who are willing and able to give written, informed consent OR
- Parents (mothers or fathers) of children who have had GBS disease (early or late onset), potentially including parents of children who have died from GBS disease who are willing and able to given written, informed consent Able to read and speak English
You may not qualify if:
- Volunteer is part of the study team at any of the study sites
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Oxfordlead
- St George's, University of Londoncollaborator
- University College, Londoncollaborator
- Imperial College Londoncollaborator
- Royal Infirmary of Edinburghcollaborator
Study Sites (4)
Edinburgh Royal Infirmary
Edinburgh, United Kingdom
Imperial College London
London, United Kingdom
St Georges University of London
London, United Kingdom
Oxford Vaccine Group, University of Oxford
Oxford, OX3 7LE, United Kingdom
Related Publications (2)
McQuaid F, Pask S, Locock L, Davis E, Stevens Z, Plumb J, Snape MD. Attitudes towards antenatal vaccination, Group B streptococcus and participation in clinical trials: Insights from focus groups and interviews of parents and healthcare professionals. Vaccine. 2016 Jul 25;34(34):4056-61. doi: 10.1016/j.vaccine.2016.06.024. Epub 2016 Jun 16.
PMID: 27318418RESULTMcQuaid F, Jones C, Stevens Z, Meddaugh G, O'Sullivan C, Donaldson B, Hughes R, Ford C, Finn A, Faust SN, Gbesemete D, Bedford H, Hughes S, Varghese AS, Heath PT, Snape MD. Antenatal vaccination against Group B streptococcus: attitudes of pregnant women and healthcare professionals in the UK towards participation in clinical trials and routine implementation. Acta Obstet Gynecol Scand. 2018 Mar;97(3):330-340. doi: 10.1111/aogs.13288. Epub 2018 Jan 19.
PMID: 29292509RESULT
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Matthew Snape, MBBS FRCPCH
University of Oxford
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 10, 2013
First Posted
November 13, 2013
Study Start
January 1, 2014
Primary Completion
March 1, 2014
Study Completion
March 29, 2014
Last Updated
April 5, 2018
Record last verified: 2018-04